Dual Energy X-Ray Absorptiometry (DXA) Transmission Methodology in Clinical Trials

Abstract

Dual Energy X-Ray Absorptiometry (DXA) has become the “gold standard” technique for the assessment of bone mineral density (BMD). More recently, this type of trial data has been handled by specialist quality assurance (QA) centers partly at the recommendation of regulatory agencies. The data are generally transmitted via paper and/or diskette from the site to the QA center. The aims of this study were to test the feasibility of transmitting these types of image flies of about 80kBytes from the investigator site to the QA center directly via modem. One hundred sixty images and related data were transmitted transat-lantically, without error and at a lower cost than using conventional methodologies. The time from patient DXA scan to QA review was also significantly shortened, thereby improving data quality further.

Keywords

Data transfer DXA Bone mineral density Orthopedics Clinical trials

Get full access to this article

View all access options for this article.

References

Cutler

Redmond

. Reducing drug development time—focus on patient recruitment. Drug Inf J. 1995;29:1709S–1718S.

Miller

. Bone density measurements in clinical trials; the challenge of ensuring optimal data. Br J Clin Res. 1993;4:113–120.

Riggs

Endocrinological and Metabolic Drugs Advisory Committee. Food and Drug Administration. March 8, 1991.

Good Clinical Practice for trials on medicinal products in the European community. July 1990.

Kanis

Geusens

Christiansen

. Guidelines for clinical trials in osteoporosis. Osteoporosis Int. 1991;1:182–188.

Ott

Yingling

. Guide to Good Clinical Practice Pub. Computer validation. Washington, DC: Thompson Publishing Group; 1995.